202 related articles for article (PubMed ID: 12087140)
1. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction.
Aviles RJ; Askari AT; Lindahl B; Wallentin L; Jia G; Ohman EM; Mahaffey KW; Newby LK; Califf RM; Simoons ML; Topol EJ; Berger P; Lauer MS
N Engl J Med; 2002 Jun; 346(26):2047-52. PubMed ID: 12087140
[TBL] [Abstract][Full Text] [Related]
2. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.
Hamm CW; Heeschen C; Goldmann B; Vahanian A; Adgey J; Miguel CM; Rutsch W; Berger J; Kootstra J; Simoons ML
N Engl J Med; 1999 May; 340(21):1623-9. PubMed ID: 10341274
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD40 ligand in acute coronary syndromes.
Heeschen C; Dimmeler S; Hamm CW; van den Brand MJ; Boersma E; Zeiher AM; Simoons ML;
N Engl J Med; 2003 Mar; 348(12):1104-11. PubMed ID: 12646667
[TBL] [Abstract][Full Text] [Related]
4. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
James SK; Lindahl B; Siegbahn A; Stridsberg M; Venge P; Armstrong P; Barnathan ES; Califf R; Topol EJ; Simoons ML; Wallentin L
Circulation; 2003 Jul; 108(3):275-81. PubMed ID: 12847065
[TBL] [Abstract][Full Text] [Related]
5. The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: the do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trial.
Berger PB; Best PJ; Topol EJ; White J; DiBattiste PM; Chan AW; Kristensen SD; Herrmann HC; Moliterno DJ
Am Heart J; 2005 May; 149(5):869-75. PubMed ID: 15894970
[TBL] [Abstract][Full Text] [Related]
6. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
Cannon CP; Weintraub WS; Demopoulos LA; Vicari R; Frey MJ; Lakkis N; Neumann FJ; Robertson DH; DeLucca PT; DiBattiste PM; Gibson CM; Braunwald E;
N Engl J Med; 2001 Jun; 344(25):1879-87. PubMed ID: 11419424
[TBL] [Abstract][Full Text] [Related]
7. A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes.
James SK; Lindahl B; Armstrong P; Califf R; Simoons ML; Venge P; Wallentin L;
Int J Cardiol; 2004 Feb; 93(2-3):113-20. PubMed ID: 14975536
[TBL] [Abstract][Full Text] [Related]
8. 5-year clinical outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary syndrome.
Damman P; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ;
J Am Coll Cardiol; 2010 Mar; 55(9):858-64. PubMed ID: 20045278
[TBL] [Abstract][Full Text] [Related]
9. Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation; a phase II study.
Akkerhuis KM; Neuhaus KL; Wilcox RG; Vahanian A; Boland JL; Hoffmann J; Baardman T; Nehmiz G; Roth U; Klootwijk AP; Deckers JW; Simoons ML;
Eur Heart J; 2000 Dec; 21(24):2042-55. PubMed ID: 11102255
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy).
James SK; Lindahl B; Timmer JR; Ottervanger JP; Siegbahn A; Stridsberg M; Armstrong P; Califf R; Wallentin L; Simoons ML
Am J Cardiol; 2006 Jan; 97(2):167-72. PubMed ID: 16442356
[TBL] [Abstract][Full Text] [Related]
11. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
Topol EJ; Moliterno DJ; Herrmann HC; Powers ER; Grines CL; Cohen DJ; Cohen EA; Bertrand M; Neumann FJ; Stone GW; DiBattiste PM; Demopoulos L;
N Engl J Med; 2001 Jun; 344(25):1888-94. PubMed ID: 11419425
[TBL] [Abstract][Full Text] [Related]
13. Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers.
Westerhout CM; Fu Y; Lauer MS; James S; Armstrong PW; Al-Hattab E; Califf RM; Simoons ML; Wallentin L; Boersma E;
J Am Coll Cardiol; 2006 Sep; 48(5):939-47. PubMed ID: 16949483
[TBL] [Abstract][Full Text] [Related]
14. Combined prognostic utility of ST segment in lead aVR and troponin T on admission in non-ST-segment elevation acute coronary syndromes.
Kosuge M; Kimura K; Ishikawa T; Ebina T; Hibi K; Tsukahara K; Kanna M; Iwahashi N; Okuda J; Nozawa N; Ozaki H; Yano H; Kusama I; Umemura S
Am J Cardiol; 2006 Feb; 97(3):334-9. PubMed ID: 16442391
[TBL] [Abstract][Full Text] [Related]
15. Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes.
Lenderink T; Heeschen C; Fichtlscherer S; Dimmeler S; Hamm CW; Zeiher AM; Simoons ML; Boersma E;
J Am Coll Cardiol; 2006 Jan; 47(2):307-11. PubMed ID: 16412852
[TBL] [Abstract][Full Text] [Related]
16. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.
Montalescot G; Barragan P; Wittenberg O; Ecollan P; Elhadad S; Villain P; Boulenc JM; Morice MC; Maillard L; Pansiéri M; Choussat R; Pinton P;
N Engl J Med; 2001 Jun; 344(25):1895-903. PubMed ID: 11419426
[TBL] [Abstract][Full Text] [Related]
17. Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trials.
Mehta RH; Greenbaum AB; Lokhnygina Y; Newby LK; Van De Werf F; Armstrong PW; Pieper KS; Califf RM; Granger CB; Harrington RA
J Interv Cardiol; 2007 Oct; 20(5):299-306. PubMed ID: 17880325
[TBL] [Abstract][Full Text] [Related]
18. Impaired myocardial perfusion score and inflammatory markers in patients undergoing primary angioplasty for acute myocardial infarction.
Exaire JE; Fathi RB; Brener SJ; Karha J; Ellis SG; Bhatt DL
Arch Cardiol Mex; 2006; 76(4):376-82. PubMed ID: 17315613
[TBL] [Abstract][Full Text] [Related]
19. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators.
Ohman EM; Armstrong PW; Christenson RH; Granger CB; Katus HA; Hamm CW; O'Hanesian MA; Wagner GS; Kleiman NS; Harrell FE; Califf RM; Topol EJ
N Engl J Med; 1996 Oct; 335(18):1333-41. PubMed ID: 8857016
[TBL] [Abstract][Full Text] [Related]
20. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators.
Hochman JS; Tamis JE; Thompson TD; Weaver WD; White HD; Van de Werf F; Aylward P; Topol EJ; Califf RM
N Engl J Med; 1999 Jul; 341(4):226-32. PubMed ID: 10413734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
